NeoGenomics, Inc. (NGNM.OB) Reports Record Quarterly Revenue of $15.7 Million, Adjusted EBITDA of $1.8 Million and 46.3% Gross Margin for the First Quarter
4/25/2013 7:52:03 AM
More...
|
NeoGenomics, Inc. (NGNM.OB) Schedules its Q1 2013 Earnings Release for April 25, 2013
4/18/2013 6:33:54 AM
More...
|
NeoGenomics, Inc. (NGNM.OB) Announces Pricing of $9.5 Million Public Offering
2/28/2013 7:34:04 AM
More...
|
NeoGenomics, Inc. (NGNM.OB) Reports 181% Increase in Adjusted EBITDA on 38% Revenue Growth and Achieves Profitability in 2012
2/14/2013 8:48:04 AM
More...
|
NeoGenomics, Inc. (NGNM.OB) Schedules its Q4 and Full Year 2012 Earnings Release for February 14, 2013
2/4/2013 10:14:48 AM
More...
|
NeoGenomics, Inc. (NGNM.OB) Validates and Launches NeoSITE™ Barrett's Esophagus FISH Test for Surveillance and Diagnosis of High Grade Dysplasia/Esophageal Cancer
12/17/2012 8:48:02 AM
More...
|
NeoGenomics, Inc. (NGNM.OB) to Ring the NASDAQ Stock Market Closing Bell
12/12/2012 9:05:28 AM
More...
|
NeoGenomics, Inc. (NGNM.OB) Announces NASDAQ Capital Market Listing
12/6/2012 9:28:15 AM
More...
|
NeoGenomics, Inc. (NGNM.OB) Reports 42% Test Volume Growth, 26% Revenue Growth and 22% Increase in Adjusted EBITDA for the Third Quarter 2012
10/31/2012 9:20:24 AM
More...
|
NeoGenomics, Inc. (NGNM.OB) Schedules its Q3 2012 Earnings Release for October 31, 2012
10/24/2012 9:09:15 AM
More...
|
|